journal article·2019-12-04Open access

Synthesis and characterization of PEG-functionalized graphene oxide as an effective pH-sensitive drug carrier

Mohamad Kazempour, Hassan Namazi, Abolfazl Akbarzadeh, Roya Kabiri

Abstract

In the present work, PEG4000 as a hydrophilic polymer was conjugated to the surface of graphene oxide (GO) for effective drug loading and targeting release of doxorubicin. The synthesized nanohybrid was characterized with scanning electron microscope (SEM), X-ray diffraction spectroscopy (XRD) and Fourier-transformed infrared spectroscopy (FTIR). Doxorubicin as an anticancer drug was immobilized on the nanohybrid surface, and the release profile at two diverse pH besides the MTT assay was investigated. The IC50 value for the nanohybrid obtained was 0.31 μg/mL. In this work, PEG4000 as a biocompatible polymer grafted on the GO surface to increase the biodispersibility of the drug carrier in a biological environment, but it is the first report of PEG 4000-GO nanohybrid-based drug carrier.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Graphene research and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Research Laboratory of Dendrimers and Nanopolymers, Faculty of Chemistry, University of Tabriz

Research Center for Pharmaceutical Nanotechnology (RCPN), Tabriz University of Medical Science

Department of Medical Nanotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences

References (33)

Show source-provided references
1. 10.1016/j.arabjc.2010.08.02210.1016/j.arabjc.2010.08.022 ↗
2. 10.1201/b1559110.1201/b15591 ↗
3. 10.1016/j.tibtech.2011.01.00810.1016/j.tibtech.2011.01.008 ↗
4. 10.3109/21691401.2014.92788010.3109/21691401.2014.927880 ↗
5. 10.1016/j.jcis.2016.11.09710.1016/j.jcis.2016.11.097 ↗
6. 10.1016/j.ijpharm.2015.10.08110.1016/j.ijpharm.2015.10.081 ↗
7. 10.1002/smll.20090168010.1002/smll.200901680 ↗
8. 10.1039/c2jm31218b10.1039/c2jm31218b ↗
9. 10.1039/B917103G10.1039/B917103G ↗
10. 10.3109/02652048.2014.94001110.3109/02652048.2014.940011 ↗
11. More MP, Patil MD, Pandey AP, et al. Fabrication and characterization of graphene-based hybrid nanocomposite: assessment of antibacterial potential and biomedical application. Artif Cells Nanomed Biotechnol. 2016;45:1–13.
12. 10.1063/1.494424210.1063/1.4944242 ↗
13. 10.1016/j.actbio.2013.08.01610.1016/j.actbio.2013.08.016 ↗
14. 10.1111/j.1472-8206.2012.01066.x10.1111/j.1472-8206.2012.01066.x ↗
15. 10.3109/0363904960910835510.3109/03639049609108355 ↗
16. Heil RW, Jr, Kenknight BH. Controlled release drug delivery. Google Patents. 2001
17. 10.1021/cr300041210.1021/cr3000412 ↗
18. 10.1016/j.synthmet.2010.07.03410.1016/j.synthmet.2010.07.034 ↗
19. 10.1021/acs.chemrev.5b0062010.1021/acs.chemrev.5b00620 ↗
20. 10.3109/21691401.2014.94464610.3109/21691401.2014.944646 ↗
21. 10.1002/9783527629930.ch510.1002/9783527629930.ch5 ↗
22. 10.3109/15569527.2011.58125710.3109/15569527.2011.581257 ↗
23. Langer R, Chasin M. Biodegradable polymers as drug delivery systems. Informa Health Care. 1990.
24. 10.1126/science.109583310.1126/science.1095833 ↗
25. 10.1016/j.colsurfb.2009.09.00110.1016/j.colsurfb.2009.09.001 ↗
26. 10.1016/j.addr.2009.02.01010.1016/j.addr.2009.02.010 ↗
27. 10.1016/j.ejpb.2006.06.00310.1016/j.ejpb.2006.06.003 ↗
28. 10.3109/0954663090344006410.3109/09546630903440064 ↗
29. 10.1039/c0cc02374d10.1039/c0cc02374d ↗
30. 10.1016/j.cherd.2015.09.00210.1016/j.cherd.2015.09.002 ↗
31. 10.1039/C3CC49325C10.1039/C3CC49325C ↗
32. 10.7314/APJCP.2014.15.20.893110.7314/APJCP.2014.15.20.8931 ↗
33. 10.1039/c2cp41988b10.1039/c2cp41988b ↗